The percentage abundance of sarcomatoid component has a prognostic role in grade 4 non-metastatic clear cell-renal carcinoma

被引：0
|
作者：
Giuseppe Lucarelli [1 ]
Francesco Lasorsa [1 ]
Monica Rutigliano [1 ]
Martina Milella [1 ]
Marco Spilotros [1 ]
Antonio d’Amati [2 ]
Giuseppe Ingravallo [2 ]
Felice Crocetto [3 ]
Savio Domenico Pandolfo [3 ]
Marco Fabiano [4 ]
Matteo Ferro [5 ]
Riccardo Autorino [6 ]
Michele Battaglia [7 ]
Pasquale Ditonno [1 ]
机构：
[1] University of Bari “Aldo Moro”,Urology, Andrology and Kidney Transplantation Unit, Department of Precision and Regenerative Medicine and Ionian Area
[2] University of Bari “Aldo Moro”,Pathology Unit, Department of Precision and Regenerative Medicine and Ionian Area
[3] University of Naples Federico II,Department of Neurosciences, Reproductive Sciences and Odontostomatology
[4] University of L’Aquila,Department of Urology
[5] “Antonio Cardarelli” Hospital,Division of Urology
[6] University of Milan,Urology Unit, Department of Health Science
[7] Rush University Medical Center,Department of Urology
来源：
World Journal of Urology | / 43卷 / 1期
关键词：
Renal cell carcinoma; Sarcomatoid; Grading; Percentage; Prognosis;
D O I：
10.1007/s00345-025-05630-4
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] DNA methylation associates with survival in non-metastatic clear cell renal cell carcinoma
    Evelonn, Emma Andersson
    Landfors, Mattias
    Haider, Zahra
    Kohn, Linda
    Ljungberg, Borje
    Roos, Goran
    Degerman, Sofie
    BMC CANCER, 2019, 19 (1)
  • [22] A critical evaluation of the prognostic value of hematological markers in non-metastatic clear cell renal cell carcinoma treated with nephrectomy
    Lee, A.
    Chen, K.
    Yuen, J.
    Sim, A.
    Tay, K. J.
    Lee, H. J.
    BJU INTERNATIONAL, 2019, 123 : 37 - 37
  • [23] UTILIZING PERCENTAGE OF SARCOMATOID DIFFERENTIATION AS A PROGNOSTIC FACTOR IN RENAL CELL CARCINOMA
    Kim, Timothy
    Dhillon, Jasreman
    Lin, Hui-Yi
    Yue, Binglin
    Fishman, Mayer
    Sverrisson, Einar
    Spiess, Philippe E.
    Gupta, Shilpa
    Pow-Sang, Julio M.
    Poch, Michael A.
    Sexton, Wade J.
    JOURNAL OF UROLOGY, 2014, 191 (04): : E322 - E322
  • [24] Using Percentage of Sarcomatoid Differentiation as a Prognostic Factor in Renal Cell Carcinoma
    Kim, Timothy
    Zargar-Shoshtari, Kamran
    Dhillon, Jasreman
    Lin, Hui-Yi
    Yue, Binglin
    Fishman, Mayer
    Sverrisson, Einar F.
    Spiess, Philippe E.
    Gupta, Shilpa
    Poch, Michael A.
    Sexton, Wade J.
    CLINICAL GENITOURINARY CANCER, 2015, 13 (03) : 225 - 230
  • [25] Non-Metastatic Clear Cell Renal Cell Carcinoma Immune Cell Infiltration Heterogeneity and Prognostic Ability in Patients Following Surgery
    Shapiro, Daniel D.
    Lozar, Taja
    Cheng, Lingxin
    Xie, Elliot
    Laklouk, Israa
    Lee, Moon Hee
    Huang, Wei
    Jarrard, David F.
    Allen, Glenn O.
    Hu, Rong
    Kinoshita, Toshi
    Esbona, Karla
    Lambert, Paul F.
    Capitini, Christian M.
    Kendziorski, Christina
    Abel, Edwin Jason
    CANCERS, 2024, 16 (03)
  • [26] IMPACT OF NECROTIC AND SARCOMATOID COMPONENTS ON ONCOLOGICAL OUTCOMES IN PATIENTS WITH NON-METASTATIC RENAL CELL CARCINOMA
    Yoo, Sangjun
    Ryu, Jeman
    Chae, Han-Kyu
    Han, Jae Hyeon
    Choi, Se Young
    You, Dalsan
    Jeong, In Gab
    Song, Cheryn
    Hong, Bumsik
    Hong, Jun Hyuk
    Ahn, Hanjong
    Kim, Choung-Soo
    JOURNAL OF UROLOGY, 2017, 197 (04): : E730 - E730
  • [27] Patient Characteristics and Survival Outcomes of Non-Metastatic, Non-Clear Cell Renal Cell Carcinoma
    An, Josiah
    Packiam, Vignesh T.
    Chennamadhavuni, Adithya
    Richards, Jordan
    Jain, Jayanshu
    Mott, Sarah L.
    Garje, Rohan
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [28] Prognostic value of systemic immune-inflammation index in non-metastatic clear cell renal cell carcinoma with tumor thrombus
    Gu, Yufeng
    Fu, Yao
    Pan, Xin
    Zhou, Yulin
    Ji, Changwei
    Zhao, Tangliang
    Miao, He
    Lv, Huichen
    Da, Jianping
    Ge, Jingping
    Wang, Linhui
    Qu, Le
    Ge, Silun
    Guo, Hongqian
    Zhou, Wenquan
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [29] Prognostic significance of ST6GalNAc-1 expression in patients with non-metastatic clear cell renal cell carcinoma
    Bai, Qi
    Liu, Li
    Xi, Wei
    Wang, Jiajun
    Xia, Yu
    Qu, Yang
    Xiong, Ying
    Long, Qilai
    Xu, Jiejie
    Guo, Jianming
    ONCOTARGET, 2018, 9 (03) : 3112 - 3120
  • [30] Immunomodulatory response to neoadjuvant nivolumab in non-metastatic clear cell renal cell carcinoma.
    Singla, Nirmish
    Nirschl, Thomas
    Obradovic, Aleksandar
    Shenderov, Eugene
    Lombardo, Kara A.
    Liu, Xiaopu
    Pons, Alice
    Zarif, Jelani
    Rowe, Steven P.
    Trock, Bruce J.
    Hammers, Hans J.
    Bivalacqua, Trinity
    Pierorazio, Phillip
    Deutsch, Julie S.
    Lotan, Tamara L.
    Taube, Janis M.
    Ged, Yasser
    Gorin, Michael A.
    Allaf, Mohamad E.
    Drake, Charles G.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
12345